The National Pharmaceutical Pricing Authority (NPPA) on Friday brings in the notice that there is a major drop or cap in the prices of 51 essential formulations which are used for the treatment of cancer, pain, heart and other skin problems, reads The Times Of India. There has been a major slashing in the price range of 6 to 53 percent. The Times of India quotes, NPPA saying that the ceiling price of 13 formulations is notified whereas the revision in the prices of 15 formulations is being done. Other than that, the 23 essential formulations will also be notified.
According to NPPA and its sources, the ceiling price of essential medicines of Schedule I under the Drugs (Prices Control) Order (DPCO) 2013. Some medicines are under the price control, while others which do not fall into the category of price control, their manufacturers are only allowed to increase the prices by 10 percent annually.
Drugs of colon or rectal cancer treatment drug oxaliplatin (injection 100mg), Japanese encephalitis vaccine and measles-rubella vaccine belong to the category whose ceiling prices have been capped.
On the other hand, ceiling prices of drugs including anaesthetic sevoflurane, Phytomenadione (Vitamin K1) and tuberculosis prevention medicine BCG vaccine have also been revised recently. However, the price of different drugs varies depending on the brand of the hospital and the doctor as well. Revision of drug prices will definitely come as a rescue to many people suffering from the life-threatening disease.